Your browser doesn't support javascript.
loading
Curative effect and safety of L-carnitine combined with alprostadil for patients with diabetic nephropathy / 药物评价研究
Drug Evaluation Research ; (6): 1481-1484, 2017.
Artigo em Chinês | WPRIM | ID: wpr-664738
ABSTRACT
Objective To explore the curative effect and safety of L-carnitine combined with alprostadil for patients with diabetic nephropathy.Methods 102 patients with diabetic nephropathy were enrolled in hospital of Inner Mongolia normal university from August 2013 to December 2016,of which patients divided into two groups randomly,control group (n =50) accepted alprostadil treatment,and combined group (n =52) adopted L-camitine based on the patients in control group.The blood glucose and renal functions were detected respectively after treatment.And the curative effect was evaluated and compared between two groups;The adverse reactions were recorded and analyzed in the period of treatment.Results After treatment,the FBP,2 h BG,24 h uPro,BUN,Scr and β2-MG of patients in two groups were decreased significantly (P < 0.05),and the change of combined group was higher than those control group significantly (P < 0.05).After treatment,the total efficiency of combined group was higher than that patients in control group (P < 0.05).The incidence of adverse reactions of control group in the period of treatment was 20.0% (10/50),and combined group was 5.8% (3/52),and which difference from two groups was no significance.Conclusions L-carnitine combined with alprostadil for patients with diabetic nephropathy deserved popularization in clinic,and which not only possessed remarkable curative effect,but also well controlled the blood glucose level,improved the renal function,decreased the incidence of adverse reactions certainly.

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Drug Evaluation Research Ano de publicação: 2017 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Drug Evaluation Research Ano de publicação: 2017 Tipo de documento: Artigo